Dexamethasone and bacterial meningitis in Pakistan.
Open accessThe DOI matches its Crossref record.
Abstract
The objective of this study was to assess, in a developing country setting, the effect of dexamethasone therapy on bacterial meningitis outcomes. A prospective double blind placebo controlled trial was conducted in 89 children aged from 2 months to 12 years suffering from bacterial meningitis. Neurological, developmental, and hearing assessments were conducted at one, four, and 12 months after discharge. Forty eight patients received dexamethasone and 41 placebo. Initial antimicrobial drugs used were ampicillin and chloramphenicol. For all patients at the time of admission the mean duration of illness was 5.7 days; 47% had had seizures and 56% had impaired consciousness. Seventeen of 89 (19%) patients died. The mortality for the dexamethasone group was 25% as compared with 12% in the group receiving placebo. Presentation to the hospital after four days of symptoms and with impaired conscious state were independent predictors of death. Of the dexamethasone group survivors, 26.5% had neurological sequelae and 42.3% had hearing impairment, whereas in the placebo group it was 24% and 30% respectively. Altered state of consciousness was a predictor of neurological sequelae. The presence of neurological sequelae and high cerebrospinal fluid protein independently predicted hearing loss. No beneficial effect of dexamethasone was observed on morbidity or mortality of this group of patients with bacterial meningitis. Dexamethasone is therefore not useful in developing countries as adjunctive treatment in patients seriously ill with bacterial meningitis, who present late for treatment and have been partially treated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Practice Guidelines for the Management of Bacterial Meningitis
Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004) · Clinical Infectious Diseases · doi:10.1086/425368 · Cited by 2,308
“There have been 15 published trials on the use of adjunctive dexamethasone in infants and children with bacterial meningitis [49–63].”
Corticosteroids for acute bacterial meningitis
Brouwer, M. C., McIntyre, P., Prasad, K., & van de Beek, D. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004405.pub5 · Cited by 809
McIntyre, P. B. (1997) · JAMA · doi:10.1001/jama.278.11.925 · Cited by 416
Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial
Molyneux, E., Walsh, A., Forsyth, H., Tembo, M., Mwenechanya, J., Kayira, K., Bwanaisa, L., Njobvu, A., Rogerson, S., & Malenga, G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09458-8 · Cited by 311
Twelve year outcomes following bacterial meningitis: further evidence for persisting effects
Grimwood, K. (2000) · Archives of Disease in Childhood · doi:10.1136/adc.83.2.111 · Cited by 276
Leppert, D., Leib, S. L., Grygar, C., Miller, K. M., Schaad, U. B., & Holländer, G. A. (2000) · Clinical Infectious Diseases · doi:10.1086/313922 · Cited by 259
A new approach for neurological evaluation of infants in resource-poor settings
Haataja, L., McGready, R., Arunjerdja, R., Simpson, J. A., Mercuri, E., Nosten, F., & Dubowitz, L. (2002) · Annals of Tropical Paediatrics · doi:10.1179/027249302125002029 · Cited by 31
Metadata
- Authors
- Qazi, S. A., Khan, M. A., Mughal, N., Ahmad, M., Joomro, B., Sakata, Y., Kuriya, N., Matsuishi, T., Abbas, K. A., & Yamashita, F.
- Venue
- Archives of Disease in Childhood
- Publisher
- BMJ
- Published
- 1996-12-01
- Volume
- 75
- Issue
- 6
- Pages
- 482-488
- ISSN
- 0003-9888 (ISSN-L)
- 1468-2044
- OpenAlex
- W2040761545
- Cited by
- 86
- References
- 0
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.